Medicine and Dentistry
Hepatocellular Carcinoma
100%
Liver Cirrhosis
51%
Hepatitis C
35%
Liver Transplantation
34%
Aspartate Aminotransferase
33%
Alanine Aminotransferase
33%
Acute Liver Failure
33%
Hepatitis C Virus
33%
Overall Survival
27%
Prevalence
26%
Liver Disease
26%
Transplantation
22%
Model For End Stage Liver Disease Score
20%
Liver Graft
19%
Model for End-Stage Liver Disease
18%
Troponin I
16%
Solid Organ Transplantation
16%
Endoscopy
16%
Metabolic Syndrome
16%
Hyperamylasemia
16%
Cohort Effect
16%
Primary Health Care
16%
Ischemic Heart Disease
16%
Esophageal Varices
16%
Esophagogastroduodenoscopy
16%
Transjugular Intrahepatic Portosystemic Shunt
16%
Survival Analysis
16%
Clostridium
16%
Bilirubin
16%
Hepatectomy
16%
Capsule Endoscopy
16%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Outpatient
16%
Alkaline Phosphatase
16%
Fulminant Hepatic Failure
16%
Hepatitis C Treatment
16%
Situs Inversus
16%
Liver Toxicity
16%
Heart Muscle Injury
16%
End Stage Liver Disease
16%
Lung Artery Pressure
16%
Allograft
16%
Malignant Neoplasm
16%
Neoplasm
14%
Hepatitis Virus
13%
Chronic Liver Disease
12%
Hyperlipidemia
11%
Counseling
11%
Disease
10%
Injury
10%
Keyphrases
Hepatocellular Carcinoma
41%
Hepatitis C
33%
Cirrhosis
29%
Liver Transplant Recipients
19%
Hepatocellular Carcinoma Surveillance
19%
Solid Organ Transplantation
16%
MELD-Na
16%
Telaprevir
16%
Abnormal Liver Chemistries
16%
Liver Chemistry Test
16%
Alanine Aminotransferase
16%
Hepatic Functional Reserve
16%
New-onset Diabetes after Transplantation
16%
Liver Allograft
16%
COVID-19
16%
Herbal Supplements
16%
Western Population
16%
Hematopoietic Cell Transplantation
16%
Natural History
16%
Hepatic Iron Overload
16%
Alcoholic Liver Disease
16%
Cardiac Iron Overload
16%
Aspartate Aminotransferase
16%
Hepatitis C Virus
16%
Mortality Prediction
16%
Hepatitis B
16%
Donor Liver
16%
Metabolic Obesity
16%
Metabolic Risk Factors
16%
Metabolic Dysfunction
16%
Metabolic Health
16%
Advanced Fibrosis
14%
Massive Bleeding
13%
United States
12%
Liver Injury
12%
Cardiac Iron
12%
Alcohol
8%
Hepatic Fibrosis
8%
Kidney Transplant Recipients
8%
Disease Stage
8%
Steatohepatitis
8%
Cardiac Transplant Recipients
8%
Hepatic Cirrhosis
8%
Difference in Temperature
8%
C. Difficile Toxin
8%
Early Tumor Detection
8%
Total Leukocyte Count
8%
Hepatitis C Virus Infection
8%
Steatosis
8%
GI Bleeding
8%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
62%
Hepatitis C
33%
Acute Liver Failure
33%
Recurrent Disease
26%
Prevalence
25%
Infection
20%
Liver Cirrhosis
20%
Ethanol
19%
Alpha Fetoprotein
16%
Telaprevir
16%
Clostridium
16%
Vitamin D-Binding Protein
16%
Hyperamylasemia
16%
Liver Cancer
16%
Metabolic Syndrome X
16%
Diarrhea
16%
Heart Muscle Injury
16%
Alcohol Liver Disease
16%
Troponin I
16%
Bilirubin
16%
Symptom
16%
Alkaline Phosphatase
16%
Alanine Aminotransferase
16%
Hepatitis B
16%
Aspartate Aminotransferase
16%
HIV
16%
Hepatitis B Core Antibody
16%
Injury
12%
Clostridium Difficile Infection
11%
Human Immunodeficiency Virus Infection
11%
Overall Survival
10%
Virus Hepatitis
10%
Liver Necrosis
8%
Chronic Liver Disease
8%
Liver Enzyme
8%
Nonalcoholic Fatty Liver
8%
Enzyme Defect
8%
Liver Cell Damage
8%
Steatosis
8%
Liver Disease
8%
Disease
8%
Liver Fibrosis
8%
Liver Injury
8%
Disease Free Survival
7%
Chronic Hepatitis C
6%
Heart Injury
6%
Leukocytosis
5%
Dietary Supplement
5%
Assessment Factor
5%
